M3 EBIT

M3 (MTHRY) currently reports a EBIT of $60B as of June 2026. That compares with $64B in the prior-year period — down 5.6% year over year. That is above the Healthcare sector average of $22B. Use the charts on this page to explore M3's EBIT history and peer comparisons.

M3's EBIT decreased from $64B to $60B — a 5.6% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

M3's EBIT of $60B is higher than the Healthcare sector average of $22B. That is roughly 170.9% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

M3 reported $60B in EBIT as of June 2026. That compares with $64B in the prior-year period — down 5.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $60B, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $22B. From there, open related valuation or income-statement pages for M3, and consider following MTHRY for alerts when major investors trade the stock.